Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heparin Induced Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Not applicableUnknownNCT03269019
What this trial is testing

Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia

Who this might be right for
Heparin-Induced ThrombocytopeniaThrombosisBiomarkers
Wuhan Asia Heart Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT05785819
What this trial is testing

VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia

Who this might be right for
Thrombocytopenia, ImmuneHeparin Induced Thrombocytopenia
Veralox Therapeutics 24
Not applicableUnknownNCT03148912
What this trial is testing

Optimizing the Diagnosis of Heparin Induced Thrombocytopenia

Who this might be right for
Heparin-induced Thrombocytopenia (HIT)
Ottawa Hospital Research Institute 180
Post-approval studies (Phase 4)WithdrawnNCT00603824
What this trial is testing

Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-Induced Thrombocytopenia
Methodist Healthcare - Memphis
Not applicableStudy completedNCT02526485
What this trial is testing

Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2

Who this might be right for
Heparin-induced Thrombocytopenia
Vanderbilt University Medical Center 15
Large-scale testing (Phase 3)Study completedNCT00198588
What this trial is testing

Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia

Who this might be right for
Heparin-Induced Thrombocytopenia
Ministry of Health, Labour and Welfare, Japan 8
Testing effectiveness (Phase 2)Temporarily pausedNCT02501434
What this trial is testing

Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin

Who this might be right for
Aneurysmal Subarachnoid HemorrhageNeurobehavioral ManifestationsVasospasm, Intracranial+2 more
Robert F. James 88
Testing effectiveness (Phase 2)Ended earlyNCT00673439
What this trial is testing

Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-Induced Thrombocytopenia
University of Louisville 3
Testing effectiveness (Phase 2)Ended earlyNCT03594045
What this trial is testing

Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-induced ThrombocytopeniaHeparin-induced Thrombocytopenia and Thrombosis
Massachusetts General Hospital 5
Large-scale testing (Phase 3)Study completedNCT00073580
What this trial is testing

Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)

Who this might be right for
ThrombocytopeniaThrombosisCardiac Disease+1 more
The Medicines Company 88
Post-approval studies (Phase 4)Ended earlyNCT00798525
What this trial is testing

Argatroban Versus Lepirudin in Critically Ill Patients

Who this might be right for
Heparin Induced Thrombocytopenia (HIT)
Heinrich-Heine University, Duesseldorf 70